London 14th March 2023: Hoptroff, the global end-to-end precision timing service solutions provider offering resilient traceable and precise time to enterprise businesses, has today announced Suzanne Ellis as its latest board member, with immediate effect.
With this appointment, Suzanne brings over 20 years of experience in large-scale transformation and change across all business functions and geographies.
Suzanne recently led the demerger of Haleon from GSK, creating a £31.5bn market cap in the FTSE 20. Before leading the demerger, Suzanne led a series of global, complex programmes including GSK-Pfizer Consumer Healthcare integration, GSK-Novartis Consumer Health Integration, GSK Supply Chain transformation, and numerous operating model changes, innovation launches, and tech and business continuous improvement projects. Moreover, Suzanne is a Non-Executive Director at Great Ormond Street Hospital.